フォロー
Michael Odo
Michael Odo
Clinical Epidemiologist; Technical Advisor at FHI 360
確認したメール アドレス: fhi360.org
タイトル
引用先
引用先
TB Infection Control in TB/HIV Settings in Cross River State, Nigeria: Policy Vs Practice
M Odo, KC Ochei, EI Obeagu, A Barinaadaa, UE Eteng, M Ikpeme, ...
Journal of Pharmaceutical Research International 32 (22), 101-109, 2020
2232020
Cascade variabilities in TB case finding among people living with HIV and the use of IPT: assessment in three levels of care in cross River State, Nigeria
M Odo, KC Ochei, EI Obeagu, A Barinaadaa, EU Eteng, M Ikpeme, ...
Journal of Pharmaceutical Research International 32 (24), 9-18, 2020
2022020
Reducing mother-to-child transmission of HIV: findings from an early infant diagnosis program in south-south region of Nigeria
C Anoje, B Aiyenigba, C Suzuki, T Badru, K Akpoigbe, M Odo, S Odafe, ...
BMC public health 12, 1-8, 2012
1402012
The missed potential of CD4 and viral load testing to improve clinical outcomes for people living with HIV in lower-resource settings
PD Ehrenkranz, SL Baptiste, H Bygrave, T Ellman, N Doi, A Grimsrud, ...
PLoS medicine 16 (5), e1002820, 2019
462019
Debunking the myths perpetuating low implementation of isoniazid preventive therapy amongst human immunodeficiency virus-infected persons
C Akolo, F Bada, E Okpokoro, O Nwanne, S Iziduh, E Usoroh, T Ali, ...
World journal of virology 4 (2), 105, 2015
212015
Evaluation of lipids and protein profiles in tuberculosis (Tb) patients on antituberculosis therapy in general hospital Umuguma, Owerri
IB Ofor, EI Obeagu, KC Ochei, M Odo
Int. J. Curr. Res. Chem. Pharm. Sci 3 (2), 20-28, 2016
142016
Impact of community based tuberculosis care interventions on TB Case detection in Nigeria–What works and what does not
B Olusola-Falae, EI Obeagu, M Odo, KC Ochei, E Solanke, T Idaboh
Int J Adv Multidiscip Res 3, 30-39, 2016
132016
Evaluation of Superoxide Dismutase, Glutathione, Vitamins C, E and Trace Element Status in Prostate Cancer Patients in Orlu Teaching Hospital, Imo State
IB Ofor, EI Obeagu, KC Ochei, M Odo
Int. J. Curr. Res. Chem. Pharm. Sci 3 (2), 29-44, 2016
102016
Isoniazid-associated pellagra during mass scale-up of tuberculosis preventive therapy: a case-control study
SA Nabity, K Mponda, S Gutreuter, D Surie, SB Zimba, L Chisuwo, ...
The Lancet Global Health 10 (5), e705-e714, 2022
92022
Intensified TB Case finding in PMTCT settings in Nigeria should be reconsidered
M Odo, EI Obeagu, KC Ochei, E Nkombe, B Olusola-Falae, E Effa, ...
Int. J. Adv. Res. Biol. Sci 3 (2), 85-92, 2016
92016
Evaluation of 6-month versus continuous isoniazid preventive therapy for Mycobacterium tuberculosis in adults living with HIV/AIDS in Malawi
YL Hsieh, A Jahn, NA Menzies, R Yaesoubi, JA Salomon, B Girma, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 85 (5), 643-650, 2020
42020
International Journal Of Current Research In Chemistry And Pharmaceutical Sciences
IB Ofor, EI Obeagu, KC OCHEI, M ODO
Int. J. Curr. Res. Chem. Pharm. Sci 3 (2), 20-28, 2016
42016
Early-phase scale-up of isoniazid preventive therapy for people living with HIV in two districts in Malawi (2017)
SA Nabity, LJ Gunde, D Surie, RW Shiraishi, HL Kirking, A Maida, AF Auld, ...
Plos one 16 (4), e0248115, 2021
32021
Protocol for a case-control study to investigate the association of pellagra with isoniazid exposure during tuberculosis preventive treatment scale-up in Malawi
SA Nabity, K Mponda, S Gutreuter, D Surie, A Williams, AJ Sharma, ...
Frontiers in Public Health 8, 551308, 2020
32020
Screening for HIV Among Patients at Tuberculosis Clinics—Results from Population-Based HIV Impact Assessment Surveys, Malawi, Zambia, and Zimbabwe, 2015–2016
N Kothegal
MMWR. Morbidity and Mortality Weekly Report 70, 2021
22021
Six months survival and risk factors for attrition for patients detected with cryptococcal antigenemia through screening in Malawi
MRO Chisale, A Jordan, PS Kamudumuli, B Mvula, M Odo, A Maida, ...
Plos one 18 (5), e0284367, 2023
12023
Liberia adherence and loss-to-follow-up in HIV and AIDS care and treatment: A retrospective cohort of adolescents and adults from 2016–2019
KL Gray, M Kiazolu, J Jones, A Konstantinova, JSW Zawolo, WMH Gray, ...
PLOS global public health 2 (3), e0000198, 2022
12022
Feasibility and cost analysis of Programmatic implementation of Microscopic-Observation Drug Susceptibility (MODS) assay in Nigeria
EA Ochang, OO Oduyebo, IA Onwuezobe, D Collier, I Bode-Sojobi, ...
Nigerian Journal of Medicine 25 (3), 226-233, 2016
12016
Perception Of Risk Of Obesity Among Adolescents In Yakurr Local Government, Cross River, Nigeria
KC Ochei, EI Obeagu, EE Ugobo, H Mbah, O Michael
European Journal of Biomedical 2 (7), 78-82, 2015
12015
Building a complementary approach to HIV service delivery for key populations using health facilities in collaboration with community-based organizations in Liberia
G Kamanga, NF Clement, T Hallie, R Lyimo, D de Mora, C Kerbay, M Odo, ...
Malawi Medical Journal 36 (2), 156-161, 2024
2024
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20